Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
RDHL
RDHL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RDHL News
Emerging Trends in H. pylori Infection Market
5d ago
Newsfilter
Analysis of Growth Drivers in the Biliary Tract Cancer Market
Mar 02 2026
Newsfilter
Talicia Full Sales Launch Begins, Unlocking Market Potential
Feb 25 2026
PRnewswire
RedHill Biopharma's RHB-102 Progress Drives 36% Rally, Stock Drops 4.29%
Jan 06 2026
Benzinga
Cyclerion Therapeutics Expands Collaboration with Medsteer, Shares Surge 44.2%
Jan 06 2026
Benzinga
RedHill Biopharma Advances RHB-102 Development, Potentially Mitigating $35 Billion Market Loss
Jan 05 2026
PRnewswire
RedHill Biopharma Reduces CLL Cells by 50% with Opaganib and Venetoclax Combination
Dec 15 2025
PRnewswire
RedHill Biopharma's Opaganib Reduces CLL Cells by 50% in Combination with Venetoclax
Dec 15 2025
Newsfilter
RedHill Biopharma Regains Nasdaq Compliance with Stockholders' Equity Exceeding $2.5 Million
Dec 01 2025
PRnewswire
RedHill Biopharma Regains Nasdaq Compliance with $2.5M Equity Requirement
Dec 01 2025
Newsfilter
RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement
Nov 04 2025
PRnewswire
RedHill Gets Notification from Nasdaq Staff Regarding Determination
Oct 22 2025
SeekingAlpha
RedHill Biopharma Receives Nasdaq Staff Determination Notification
Oct 22 2025
PRnewswire
RedHill's Talicia® Obtains $4 Million Strategic Investment and U.S. Co-Commercialization Agreement
Oct 20 2025
Newsfilter
CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO
Oct 20 2025
PRnewswire
RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
Oct 20 2025
PRnewswire
Show More News
